发明名称 |
ULIPRISTAL ACETATE TABLETS |
摘要 |
The invention relates to a pharmaceutical tablet for oral administration comprising ulipristal acetate together with the following excipients: at least one diluent in an amount of 50 to 98.5 wt %, at least one binding agent in an amount of 0 to 10 wt %, at least one disintegrating agent in an amount of 0.5 to 10 wt %, and at least one lubricant in an amount of 0 to 10 wt %. |
申请公布号 |
US2016287518(A1) |
申请公布日期 |
2016.10.06 |
申请号 |
US201615185508 |
申请日期 |
2016.06.17 |
申请人 |
Laboratoire HRA PHARMA |
发明人 |
Gainer Erin;Guillard Helene;Gicquel Denis;Henrion Marianne;Gnakamene Celine |
分类号 |
A61K9/20;A61K31/57 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
1. An oral pharmaceutical tablet comprising ulipristal acetate in an amount ranging from 1 mg to 50 mg, a diluent, a disintegrating agent, and a lubricant, wherein at least 80% of ulipristal acetate present in the tablet is dissolved within about 20 minutes when said tablet is subjected to an in vitro dissolution assay in a paddle apparatus at 37° C.±0.5° C., and at pH=1. |
地址 |
Paris FR |